Stock listing
Oragenics Inc.
Selected listing: OGEN · AMEX · USD · US
Oragenics Inc. (NYSE American: OGEN), Health Technology. Latest release May 19, 2026: Oragenics : Investor Presentation - May 2026.
- Ticker
- NYSE American: OGEN
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NYSE American
- Currency
- USD
About Oragenics Inc.
Oragenics Inc. is a public company traded under the ticker OGEN in the American market. Oragenics focuses on developing innovative solutions in the biotechnology sector.
Latest news from Oragenics Inc.
Oragenics : Investor Presentation - May 2026
May 19, 2026
ORAGENICS PROVIDES INVESTOR UPDATE
May 18, 2026
Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
May 7, 2026
Oragenics Activates Second Site in Phase IIa Clinical Trial of ONP-002 for Concussion and Mild Traumatic Brain Injury.
May 5, 2026
Oragenics Reports 8 study drug doses in Phase IIa Clinical Trial of ONP-002 for Mild Traumatic Brain Injury
April 20, 2026
Research Oragenics Inc.
Alternate listings
OGEN:BOATS
US · USD
Alternate listing for Oragenics Inc.; the primary context on this page is OGEN:AMEX.
UAV0:GETTEX
DE · EUR
Alternate listing for Oragenics Inc.; the primary context on this page is OGEN:AMEX.
0A64:LSE
GB · USD
Alternate listing for Oragenics Inc.; the primary context on this page is OGEN:AMEX.
UAV0:MUN
DE · EUR
Alternate listing for Oragenics Inc.; the primary context on this page is OGEN:AMEX.